Burning Fat Muscling Sr9011 1379686-30-2

Email:[email protected]
Skype:live:kathelin_4
WhataApp:+86-188 7222 0706

MOQ:10G

Contact with me if any interested.

 Burning Fat Muscling Sr9011 1379686-30-2
SR9009 (Stenabolic)Description:
SR9009, which is currently under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice. Treated mice become lean, develop larger muscles and can run much longer distances simply by taking SR9009, which mimics the effects of aerobic exercise. If similar effects can be obtained in people, the reversal of obesity, metabolic syndrome, and perhaps Type-II diabetes might be the very welcome result.

SR9009 Spec.
Superlist Name: SR9009
Molecular Formula: C20H24ClN3O4S
CAS No.: 1379686-30-2
Purity: 99%
Synonyms: Ethyl-3-(((4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino)methyl)pyrrolidine-1-carboxylate
Molecular Weight: 437.94
Appearance: White powder
Solubility: DMSO
Grade:	Pharmaceutical Grade
Usage: under development at The Scripps Research Institute (TSRI), increases
the level of metabolic activity in skeletal muscles of mice

Application:
SR9009 increase exercise endurance and loss weight.
SR9009 is a research drug that was developed by Professor Thomas Burris of the Scripps Research Institute as an agonistof Rev-ErbA (i.e., increases the constitutive repression of genes regulated by Rev-ErbA) with a half-maximum inhibitory concentration (IC50) = 670 nM for Rev-ErbAα and IC50 = 800 nM for Rev-ErbAβ.
Activation of Rev-erb-α by in mice SR9009 increases exercise capacity in mice by increasing mitochondria in skeletal muscle.